| Announcement Title | Change - Announcement of Appointment |
| Date & Time of Broadcast | Nov 17, 2023 19:51 |
| Status | New |
| Announcement Sub Title | Appointment of Non-Executive Director and NRC Member |
| Announcement Reference | SG231117OTHRHDRJ |
| Submitted By (Co./ Ind. Name) | Yong Yean Chau |
| Designation | Director / Chief Executive Officer |
| Description (Please provide a detailed description of the event in the box below) | Appointment of Non-Executive Director and NRC Member |
| Additional Details | |
| Date Of Appointment | 17/11/2023 |
| Name Of Person | Dr. Prem Kumar Nair |
| Age | 63 |
| Country Of Principal Residence | Singapore |
| The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process) | Dr. Prem Kumar Nair was nominated by Parkway Holdings Limited, the holding company of Parkway Trust Management Limited (Company). The Nominating and Remuneration Committee of the Company (NRC) has reviewed the qualification and experience of Dr. Prem Kumar Nair and recommended to the Board the appointment of Dr. Prem Kumar Nair as a Non-Executive Director and member of the NRC of the Company. The Board considered the recommendation of NRC and approved his appointment. |
| Whether appointment is executive, and if so, the area of responsibility | Non-executive |
| Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Non-Executive Director and NRC Member |
| Professional qualifications | - Bachelor of Medicine & Bachelor of Surgery (MBBS) - National University of Singapore - Master of Business Administration (Distinction) - Manchester Business School, United Kingdom |
| Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries | Dr. Prem Kumar Nair is the Group Chief Executive Officer of IHH Healthcare Berhad, a substantial shareholder of Parkway Life REIT |
| Conflict of interests (including any competing business) | Nil, except for the position of Group Chief Executive Officer held by Dr. Prem Kumar Nair in IHH Healthcare Berhad and various directorships in subsidiaries of IHH Healthcare Berhad |
| Working experience and occupation(s) during the past 10 years | - 1 October 2023 to Present - Group Chief Executive Officer, IHH Healthcare Berhad - 2020 to 30 September 2023 - Chief Executive Officer, Singapore of IHH Healthcare Berhad - 2018 to 2020 - Associate Professor of National University of Singapore - 1990 to 2017 - Chief Corporate Officer/Managing Director, Singapore Healthcare of Raffles Medical Group Ltd |
| Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6)) | Yes |
| Shareholding interest in the listed issuer and its subsidiaries? | No |
| # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8). | |
| Past (for the last 5 years) | Please refer to Annexure A attached |
| Present | Please refer to Annexure B attached |
| (a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? | No |
| (b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? | No |
| (c) Whether there is any unsatisfied judgment against him? | No |
| (d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? | No |
| (e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? | No |
| (f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? | No |
| (g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? | No |
| (h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? | No |
| (i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? | No |
| (j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :- | |
| (i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or | No |
| (ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or | No |
| (iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or | No |
| (iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? | No |
| (k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? | No |
| Any prior experience as a director of an issuer listed on the Exchange? | No |
| If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange | Dr. Prem Kumar Nair will be attending training on the roles and responsibilities as a director of a listed issuer as prescribed by the Exchange. |
Attachments
The information behind this electronic gatepost is only being made available to residents of Singapore.
In particular, the units of Parkway Life Real Estate Investment Trust have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), and may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the U.S. Securities Act.
The units of Parkway Life Real Estate Investment Trust are only being offered outside the United States in reliance on Regulation S under the U.S. Securities Act or otherwise pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the U.S.
By clicking on the "I agree" button below, you will have acknowledged the foregoing restrictions and represented that you are resident in Singapore and are not accessing this website from jurisdictions outside of Singapore, including the United States.